Literature DB >> 10642764

Aortic laceration secondary to palmaz stent placement for treatment of superior vena cava syndrome.

J Evans1, Z Saba, H Rosenfeld, L Thompson, R Williams.   

Abstract

Aortic laceration secondary to Palmaz Stent placement for treatment of superior vena cava syndrome is reported. This potentially life-threatening complication should be considered when rigid balloon expandable stents are used to treat superior vena cava syndrome of benign origin. Cathet. Cardiovasc. Intervent. 49:160-162, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh：

Year:  2000        PMID： 10642764     DOI： 10.1002/(sici)1522-726x(200002)49:2<160::aid-ccd9>3.0.co;2-8

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN： 1522-1946            Impact factor:   2.692


  5 in total

Review 1.  Superior Vena Cava Rupture and Cardiac Tamponade Complicating the Endovascular Treatment of Malignant Superior Vena Cava Syndrome: A Case Report and Literature Review.

Authors:  David C Stevens; Sabah Butty; Matthew S Johnson
Journal:  Semin Intervent Radiol       Date:  2015-12       Impact factor: 1.513

2.  Initial experience using the NuMED Cheatham Platinum (CP) stent for interventional treatment of coarctation of the aorta in children and adolescents.

Authors:  N A Haas; M A G Lewin; W Knirsch; R Nossal; V Ocker; F Uhlemann
Journal:  Z Kardiol       Date:  2005-02

3.  Use of stents for the maintenance of hemodialysis access.

Authors:  Jonathan M Lorenz
Journal:  Semin Intervent Radiol       Date:  2004-06       Impact factor: 1.513

4.  Cardiac tamponade after superior vena cava stenting.

Authors:  Kale S Bongers; Vaiibhav Patel; Sarah K Gualano; Richard J Schildhouse
Journal:  BMJ Case Rep       Date:  2020-06-29

5.  Hybrid treatment of an aortic pseudoaneurysm arising at the innominate artery junction secondary to superior vena cava stenting.

Authors:  Arnaud Roussel; Dominique Fabre; Elie Fadel; Claude Angel; Philippe Dartevelle
Journal:  J Vasc Surg Cases       Date:  2015-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.